Testing effectiveness (Phase 2)Study completedNCT00928174
What this trial is testing
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Who this might be right for
Prostate Cancer
Queen's Medical Center 27